NO940972D0 - Nye - Google Patents

Nye

Info

Publication number
NO940972D0
NO940972D0 NO940972A NO940972A NO940972D0 NO 940972 D0 NO940972 D0 NO 940972D0 NO 940972 A NO940972 A NO 940972A NO 940972 A NO940972 A NO 940972A NO 940972 D0 NO940972 D0 NO 940972D0
Authority
NO
Norway
Prior art keywords
alpha
beta
pyrindine
tetrols
octahydro
Prior art date
Application number
NO940972A
Other languages
English (en)
Other versions
NO300372B1 (no
NO940972L (no
Inventor
Robert A Farr
Mohinder Singh Kang
Norton Paul Peet
Sai Prasad Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO940972D0 publication Critical patent/NO940972D0/no
Publication of NO940972L publication Critical patent/NO940972L/no
Publication of NO300372B1 publication Critical patent/NO300372B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
NO940972A 1991-09-18 1994-03-17 Nye <alfa>-mannosidaseinhibitorer NO300372B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors
PCT/US1992/006707 WO1993005781A1 (en) 1991-09-18 1992-08-10 Novel alpha-mannosidase inhibitors

Publications (3)

Publication Number Publication Date
NO940972D0 true NO940972D0 (no) 1994-03-17
NO940972L NO940972L (no) 1994-03-17
NO300372B1 NO300372B1 (no) 1997-05-20

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940972A NO300372B1 (no) 1991-09-18 1994-03-17 Nye <alfa>-mannosidaseinhibitorer

Country Status (15)

Country Link
US (1) US5262425A (no)
EP (1) EP0641327B1 (no)
JP (1) JP3226173B2 (no)
KR (1) KR100244012B1 (no)
AT (1) ATE175960T1 (no)
AU (1) AU659486B2 (no)
CA (1) CA2116224C (no)
DE (1) DE69228259T2 (no)
DK (1) DK0641327T3 (no)
ES (1) ES2127758T3 (no)
FI (1) FI105270B (no)
GR (1) GR3029745T3 (no)
HU (1) HU216789B (no)
NO (1) NO300372B1 (no)
WO (1) WO1993005781A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
EP0934318A1 (en) * 1996-10-01 1999-08-11 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
HU216789B (hu) 1999-08-30
JP3226173B2 (ja) 2001-11-05
EP0641327B1 (en) 1999-01-20
CA2116224C (en) 2003-06-03
US5262425A (en) 1993-11-16
FI941259A (fi) 1994-03-17
GR3029745T3 (en) 1999-06-30
WO1993005781A1 (en) 1993-04-01
ES2127758T3 (es) 1999-05-01
JPH06510785A (ja) 1994-12-01
AU2477192A (en) 1993-04-27
HU9400787D0 (en) 1994-06-28
HUT70527A (en) 1995-10-30
FI105270B (fi) 2000-07-14
ATE175960T1 (de) 1999-02-15
FI941259A0 (fi) 1994-03-17
AU659486B2 (en) 1995-05-18
DE69228259T2 (de) 1999-06-02
EP0641327A4 (en) 1994-06-01
NO300372B1 (no) 1997-05-20
NO940972L (no) 1994-03-17
CA2116224A1 (en) 1993-04-01
KR100244012B1 (ko) 2000-03-02
DK0641327T3 (da) 1999-09-13
DE69228259D1 (de) 1999-03-04
EP0641327A1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
CO4290353A1 (es) Agonistas de estrogeno
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
ES2117034T3 (es) Composicion para la limpieza de vidrio.
DE69516866T2 (de) Stereochemische wortmanninderivate
PT92146A (pt) Processo para a preparacao do inibidor de glicosidade salbostatina e de composicoes farmaceuticas que a contem
NO925041D0 (no) Nye 2-sakkarinylmetylaryl- og aryloksyacetater som er nyttige som proteolytiske enzymerinhibitorer
NO932547L (no) Isoksazolederivater for behandling av irritabelt tarmsyndrom
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
NO940972D0 (no) Nye
NO871809L (no) Smoeremidler og nye polyfluorerte forbindelser til bruk som additiver
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
HUT60994A (en) Process for producing 2,3,4-trihydroxy-5-(hydroxymethyl)-cyclopentyl amine derivatives
DK0566666T3 (da) Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
MX9305453A (es) Metodo para tratar infecciones virales.
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
IT9020228A0 (it) Apparato per trattamenti igienicizzanti di foraggi o simili
ITMI912767A0 (it) Processo per la dealogenazione di derivati del naftalene
PL292747A1 (en) Method of obtaining novel (-)-trans-4-(2-(n,n-diethylamine) ethoxyl)-cis-crane
IT1231065B (it) Dispositivo per eseguire l&#39;asportazione chirurgica di segmenti di organi, per esempio segmenti epatici.